Persistence of asthma biologic use in a US claims database

Jacob T Maddux,Jonathan W Inselman,Molly M Jeffery,Regina W Lam,Nilay D Shah,Matthew A Rank

Annals of Allergy, Asthma & Immunology（2021）

引用 1|浏览2

暂无评分

摘要

Between 48% and 64% of people remained on an asthma biologic for ≥6 months after first use. Most people who achieved a reduction in asthma exacerbations did so in the first 6 months of treatment.

查看译文

关键词

Asthma,Benralizumab,Biologics,Dupilumab,Mepolizumab,Omalizumab,Persistence,Reslizumab

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要